Drugs News and Research

RSS

Guide to minimize microbial food safety hazards of fresh-cut fruits and vegetables

The Food and Drug Administration (FDA) today published a draft final guidance advising processors of fresh-cut produce how to minimize microbial food safety hazards common to the processing of most fresh-cut fruits and vegetables, which are often sold to consumers in a ready-to-eat form.

12 Mar 2007

$20 million boosts AIDS treatment, vaccine research in Rochester

The University of Rochester Medical Center will continue to play a leading role in the nation’s effort fighting AIDS, with more than $20 million to be directed to Rochester doctors and researchers who are working on new treatments for the disease and on finding a vaccine to prevent it altogether, Federal officials announced today.

12 Mar 2007

New guidelines on cultivating Artemisia plant used in anti-malaria medicines

The World Health Organization (WHO) has published guidelines for the cultivation and collection of Artemisia (Artemisia annua L., Asteraceae), known in the United States as sweet Annie or annual wormwood, a Chinese traditional medicinal plant which is the source of artemisinin, used to produce the most effective medicines for malaria.

12 Mar 2007

Antifungal drug kills tuberculosis bug

Scientists hoping to find new treatments for one of the world's most deadly infectious diseases say drugs used to treat common fungal infections may provide the answer.

From The University of Manchester 12 Mar 2007

Stem cells delay neurodegeneration in the brain

Sufferers from devastating neurodegenerative diseases have been given some hope by the results of recent research.

12 Mar 2007

FDA strengthens safety information for Erythropoiesis-Stimulating Agents (ESAs)

The U.S. Food and Drug Administration (FDA) has issued a public health advisory outlining new safety information, including revised product labeling about erythropoiesis-stimulating agents (ESAs), widely-used drugs for the treatment of anemia.

11 Mar 2007

CMS investigates allegations that Humana encouraged its highest-cost beneficiaries to join competing Medicare prescription drug plan

CMS officials are investigating whether Humana inappropriately advised the highest-cost beneficiaries in its Medicare prescription drug benefit plans to switch to plans provided by Sierra Health Services, The Hill reports.

11 Mar 2007

Vietnam launches program to stabilize HIV prevalence in 2007

Vietnam's Ministry of Health has launched a program to stabilize the country's HIV prevalence in 2007, the Vietnam News Agency reports.

11 Mar 2007

Some Puerto Rican clinics limiting HIV/AIDS services following suspension of reimbursements from Ryan White progra

Some clinics in San Juan, Puerto Rico, have begun rationing drugs for hundreds of HIV-positive people, while other organizations have reduced food supplies and services, since they stopped receiving reimbursements from the Ryan White Program, the AP/AOL News reports.

11 Mar 2007

Advocates call on Kroger Pharmacies to make emergency contraceptive Plan B available

Advocates are calling on Cincinnati-based Kroger stores to make the emergency contraceptive Plan B available to women at its pharmacies after a Georgia woman said a store did not sell her the drug, the AP/Akron Beacon Journal reports.

11 Mar 2007

Islet cell trasnplant without immunosuppressive drugs successful in mice

Scientists at Weill Cornell Medical College may have reached a breakthrough in the search for a lasting cure for type 1 diabetes.

11 Mar 2007

Drug resistant headache pain eased by brain stimulation

Researchers in Britain and the United States have found that the extreme pain of cluster headaches can be eased by electrodes.

11 Mar 2007

FDA needs authority to approve generic biologics

AARP called on Congress today to give the Food and Drug Administration (FDA) the authority to approve safe, cost-effective generic versions of often expensive biologic drug therapies.

8 Mar 2007

Gene that prevents cancer also controls the skin's suntanning machinery

"The p53 tumor suppressor is commonly mutated in human cancer," explained David Fisher, director of the Melanoma Program in Medical Oncology at Dana-Farber Cancer Institute. "Now, we've found that it plays a role in the skin's tanning response."

8 Mar 2007

ARIUS Research granted two new U.S. patents for antibodies

ARIUS Research has announced that it has been granted two new United States patents for antibodies within their CD63 program. Patent 7,175,846. covers anti-cancer antibodies in ARIUS' partnered program for melanoma, breast and prostate cancers and protects the valuable site on the disease target that the drug candidate binds to.

8 Mar 2007

Novartis to continue Indian patent fight

Novartis CEO Daniel Vasella on Tuesday at the company's annual general meeting said that the drug maker plans to continue a lawsuit challenging a section of India's Patents Act that aims to restrict certain kinds of patents, despite criticism from some HIV/AIDS advocacy groups and shareholders, Reuters reports

8 Mar 2007

HIV/AIDS services in Myanmar being pulled due to Government pressure

An increasing number of international organizations and health workers have stopped offering HIV/AIDS services in Myanmar because of pressure from the country's military government, the Washington Times reports.

8 Mar 2007

Doctors in Zimbabwe end two-month strike

Doctors in Zimbabwe have ended a two-month strike after reaching a deal with the government over their wages, Health Minister David Parirenyatwa said on Saturday, Reuters South Africa reports.

8 Mar 2007

Bold proposal to restructure drug development patents

Weill Cornell Medical College scientist Dr. Carl Nathan has issued a bold call for reforming the pharmaceutical development and patent systems in order to increase the number of vaccines and drugs available to combat neglected diseases that are ravaging the world's poor.

8 Mar 2007

Allowing greater access to drug safety data would enable researchers to better evaluate risks

For years, pharmaceutical companies have sought to restrict public access to drug safety data collected in clinical trials on the basis that it is proprietary information, arguing that competitors could use that information in the development of their own products.

8 Mar 2007